Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
31.51 USD | -3.14% | +5.53% | -23.33% |
May. 14 | Transcript : Sanara MedTech Inc., Q1 2024 Earnings Call, May 14, 2024 | |
May. 13 | Sanara MedTech Q1 Net Loss Widens, Revenue Increases -- Shares Down | MT |
Financials (USD)
Sales 2024 * | 78M | Sales 2025 * | - | Capitalization | 272M |
---|---|---|---|---|---|
Net income 2024 * | -1M | Net income 2025 * | 4M | EV / Sales 2024 * | 3.48 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-143
x | P/E ratio 2025 * |
56.3
x | Employees | 108 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 39.95% |
Latest transcript on Sanara MedTech Inc.
1 day | -3.14% | ||
1 week | +5.53% | ||
Current month | -1.04% | ||
1 month | -6.75% | ||
3 months | -16.09% | ||
6 months | +3.31% | ||
Current year | -23.33% |
Managers | Title | Age | Since |
---|---|---|---|
Michael McNeil
DFI | Director of Finance/CFO | 59 | 18-04-10 |
Chief Tech/Sci/R&D Officer | - | 22-12-31 | |
Chief Tech/Sci/R&D Officer | 39 | 21-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Eric Tanzberger
BRD | Director/Board Member | 55 | 21-12-31 |
Roszell Mack
BRD | Director/Board Member | 57 | 21-12-31 |
Eric Major
BRD | Director/Board Member | 55 | 23-05-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 34 M€ | +4.77% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-21 | 31.51 | -3.14% | 6,321 |
24-05-20 | 32.53 | +6.62% | 12,948 |
24-05-17 | 30.51 | -3.75% | 17,482 |
24-05-16 | 31.7 | -6.93% | 15,147 |
24-05-15 | 34.06 | +14.07% | 31,362 |
Delayed Quote Nasdaq, May 21, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-23.33% | 272M | |
+37.78% | 723B | |
+32.82% | 598B | |
-3.51% | 364B | |
+19.94% | 331B | |
+5.14% | 288B | |
+16.64% | 244B | |
-4.13% | 208B | |
+10.63% | 210B | |
+9.32% | 169B |
- Stock Market
- Equities
- SMTI Stock